Mohammad M Zarshenas Selected Research

Persian Medicine

1/2021	Assessment of the Cytotoxic Activity of Triphala: A Semisolid Traditional Formulation on HepG2 Cancer Cell Line.
1/2020	A panoramic view of medicinal plants traditionally applied for impotence and erectile dysfunction in Persian medicine.
1/2020	Overview of herbal and traditional remedies in the treatment of cutaneous leishmaniasis based on Traditional Persian Medicine.
11/2019	Holistic Approach to Functional Constipation: Perspective of Traditional Persian Medicine.
1/2018	A Review of Herbal Remedies for Multiple Sclerosis-Like Disorders in Traditional Persian Medicine (TPM).
1/2018	Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome.
11/2017	Botanical Sources for Alzheimer's: A Review on Reports From Traditional Persian Medicine.
10/2017	An Evidence-Based Study on Medicinal Plants for Hemorrhoids in Medieval Persia.
1/2017	A Randomized Clinical Trial on Treatment of Chronic Constipation by Traditional Persian Medicine Recommendations Compared to Allopathic Medicine: A Pilot Study.
1/2016	A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad M Zarshenas Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 01/2019
5	Constipation 11/2019 - 01/2015
2	COVID-19 04/2021 - 10/2020
2	Liver Diseases (Liver Disease) 01/2021 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2017
2	Pain (Aches) 01/2021 - 01/2016
2	Chronic Disease (Chronic Diseases) 01/2021 - 11/2019
2	Cutaneous Leishmaniasis 01/2020 - 01/2017
2	Diabetes Mellitus 01/2017 - 03/2014
1	Wounds and Injuries (Trauma) 11/2022
1	Burns 11/2022
1	Insulin Resistance 01/2022
1	Abdominal Obesity 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Virus Diseases (Viral Diseases) 04/2021
1	Hypothyroidism 01/2021
1	Alopecia (Baldness) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Toxoplasmosis 01/2021
1	Erectile Dysfunction 01/2020
1	Leishmaniasis 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Multiple Sclerosis 01/2018
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2018
1	Hemorrhoids 10/2017
1	Gingivitis 01/2017
1	Diarrhea 01/2017
1	Polydipsia 05/2016
1	Hyperphagia (Overeating) 05/2016
1	Fever (Fevers) 01/2016
1	Rheumatoid Arthritis 01/2016
1	Ulcer 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Osteoarthritis 01/2016
1	Flatulence 12/2015
1	Dyspepsia (Indigestion) 04/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2014
1	Headache (Headaches) 01/2013
1	Tremor (Tremors) 01/2013

Drug/Important Bio-Agent (IBA)

4	AntioxidantsIBA 01/2022 - 01/2016
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2013
3	Plant ExtractsIBA 01/2021 - 11/2017
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2021
2	Free RadicalsIBA 01/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 01/2021
2	AntidiarrhealsIBA 01/2021 - 01/2017
2	Lactulose (Duphalac)FDA LinkGeneric 01/2017 - 12/2015
1	ChitosanIBA 11/2022
1	polycaprolactoneIBA 11/2022
1	Safflower Oil FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	AdiponectinIBA 01/2022
1	VaccinesIBA 04/2021
1	Pharmaceutical PreparationsIBA 04/2021
1	AlkaloidsIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	PhytochemicalsIBA 01/2021
1	Parasympatholytics (Antispasmodics)IBA 01/2021
1	Harmine (Telepathine)IBA 01/2021
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 01/2021
1	Glycogen Synthase Kinase 3IBA 01/2021
1	EnzymesIBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	triphalaIBA 01/2021
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	ChlorhexidineIBA 01/2017
1	TeaIBA 01/2017
1	Volatile Oils (Essential Oils)IBA 01/2016
1	NitrogenIBA 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2015
1	ElectrolytesIBA 04/2015
1	LaxativesIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2014

Therapy/Procedure

16	Persian Medicine 01/2021 - 01/2013
3	Therapeutics 04/2021 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
1	Leeching 01/2017
1	Massage (Zone Therapy) 05/2016
1	Traditional Medicine (Folk Remedies) 01/2016